Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2005-12-23 · Nuclear Regulatory Commission · Rules and Regulations

Rules and Regulations. Notice of availability

1,309 words·~6 min read·/register/2005/12/23/05-24429·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Agency: Nuclear Regulatory Commission
Action: Notice of availability
Citation: FR Doc. 05-24429 · Docket Nos. 52-009-ESP and ASLBP No. 04-823-03-ESP · FR Doc. E5-7782 Filed 12-22-05; 8:45 am

Supplementary Information

I. Introduction The U.S. Nuclear Regulatory Commission (NRC) is considering the issuance of a license amendment to the Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health (FDA/CDRH) for Materials License No. 19-07538-01, to authorize release of its facility at 12709 Twinbrook Parkway, Rockville, Maryland for unrestricted use. NRC has prepared an Environmental Assessment (EA) in support of this proposed action in accordance with the requirements of 10 CFR Part 51. Based on the EA, the NRC has concluded that a Finding of No Significant Impact (FONSI) is appropriate. II. EA Summary The purpose of the proposed action is to authorize the release of the licensee's 12709 Twinbrook Parkway, Rockville, Maryland facility for unrestricted use. FDA/CDRH was authorized by NRC from 1965 to use radioactive materials for research and development purposes at the site. On August 23, 2005, FDA/CDRH requested that NRC release the facility for unrestricted use. FDA/CDRH has conducted surveys of the facility and provided information to the NRC to demonstrate that the site meets the license termination criteria in Subpart E of 10 CFR Part 20 for unrestricted use. The NRC staff has prepared an EA in support of the license amendment. The facility was remediated and surveyed prior to the licensee requesting the license amendment. The NRC staff has reviewed the information and final status survey submitted by FDA/CDRH. Based on its review, the staff has determined that there are no additional remediation activities necessary to complete the proposed action. Therefore, the staff considered the impact of the residual radioactivity at the facility and concluded that since the residual radioactivity meets the requirements in Subpart E of 10 CFR part 20, a Finding of No Significant Impact is appropriate. III. Finding of No Significant Impact The staff has prepared the EA (summarized above) in support of the license amendment to terminate the license and release the facility for unrestricted use. The NRC staff has evaluated FDA/CDRH's request and the results of the surveys and has concluded that the completed action complies with the criteria in Subpart E of 10 CFR Part 20. The staff has found that the radiological environmental impacts from the action are bounded by the impacts evaluated by NUREG-1496, Volumes 1-3, “Generic Environmental Impact Statement in Support of Rulemaking on Radiological Criteria for License Termination of NRC-Licensed Facilities” (ML042310492, ML042320379, and ML042330385). Additionally, no non-radiological or cumulative impacts were identified. On the basis of the EA, the NRC has concluded that there are no significant environmental impacts from the proposed action, and has determined not to prepare an environmental impact statement for the proposed action. IV. Further Information Documents related to this action, including the application for the license amendment and supporting documentation, are available electronically at the NRC's Electronic Reading Room at . From this site, you can access the NRC's Agencywide Document Access and Management System (ADAMS), which provides text and image files of NRC's public documents. The ADAMS accession numbers for the documents related to this Notice are: Environmental Assessment [ML053480176] and Final Status Survey Report, Food and Drug Administration, Center for Devices and Radiological Health, 12709 Twinbrook Parkway, Rockville, Maryland, August 22, 2005, Final Report [ML052380179]. Persons who do not have access to ADAMS or who encounter problems in accessing the documents located in ADAMS, should contact the NRC PDR Reference staff by telephone at (800) 397-4209 or (301) 415-4737, or by e-mail to . Documents related to operations conducted under this license not specifically referenced in this Notice may not be electronically available and/or may not be publicly available. Persons who have an interest in reviewing these documents should submit a request to NRC under the Freedom of Information Act (FOIA). Instructions for submitting a FOIA request can be found on the NRC's Web site at . Dated at King of Prussia, Pennsylvania this 14th day of December, 2005. For the Nuclear Regulatory Commission John D. Kinneman, Chief Materials Security & Industrial Branch, Division of Nuclear Materials Safety. Region I. [FR Doc. E5-7792 Filed 12-22-05; 8:45 am] BILLING CODE 7590-01-P NUCLEAR REGULATORY COMMISSION Advisory Committee on Reactor Safeguards; Subcommittee Meeting on Thermal-Hydraulic Phenomena; Notice of Meeting The ACRS Subcommittee on Thermal-Hydraulic Phenomena will hold a meeting on January 19, 2006, Room T-2B3, 11545 Rockville Pike, Rockville, Maryland. The entire meeting will be open to public attendance, with the exception of portions that may be closed to discuss General Electric (GE) proprietary information pursuant to 5 U.S.C. 552b(c)(4). The agenda for the subject meeting shall be as follows: Thursday, January 19, 2006—8:30 a.m. Until the Conclusion of Business The Subcommittee will review the analytical methods to be used to evaluate stability scenarios for the ESBWR and will hear the NRC staff's plan to revise Regulatory Guide 1.82, “Water Sources for Long-Term Recirculation Cooling Following a Loss-of-Coolant Accident.” The Subcommittee will hear presentations by and hold discussions with representatives of the NRC staff, their contractors, GE and other interested persons regarding this matter. The Subcommittee will gather information, analyze relevant issues and facts, and formulate proposed positions and actions, as appropriate, for deliberation by the full Committee. Members of the public desiring to provide oral statements and/or written comments should notify the Designated Federal Official, Mr. Ralph Caruso (Telephone: 301-415-8065) five days prior to the meeting, if possible, so that appropriate arrangements can be made. Electronic recordings will be permitted only during those portions of the meeting that are open to the public. Further information regarding this meeting can be obtained by contacting the Designated Federal Official between 7:30 a.m. and 4:15 p.m. (ET). Persons planning to attend this meeting are urged to contact the above named individual at least two working days prior to the meeting to be advised of any potential changes to the agenda. Dated: December 15, 2005. Michael L. Scott, Branch Chief, ACRS/ACNW. [FR Doc. 05-24429 Filed 12-22-05; 8:45 am]

Connectionstraces to 3
3 references not yet in our index
  • 10 CFR 52
  • 10 CFR 51
  • 10 CFR 20
Citation graph
cites case law
Rules and Regulations
Notice of availability
Cite10 CFR 52
Cite10 CFR 51
Cite10 CFR 20
Cites 6Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.